S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
How to Choose a Brokerage Account or Online Broker
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
What is a Mutual Fund? How Does it Work?
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
How to Choose a Brokerage Account or Online Broker
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
What is a Mutual Fund? How Does it Work?
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
How to Choose a Brokerage Account or Online Broker
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
What is a Mutual Fund? How Does it Work?
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
How to Choose a Brokerage Account or Online Broker
BREAKING: Tiny biotech successfully treats blindness (Ad)
Tax Software Specialist Vertex In Buy Zone After Base Breakout
What is a Mutual Fund? How Does it Work?
NASDAQ:MIST

Milestone Pharmaceuticals (MIST) Earnings Date, Estimates & Call Transcripts

$3.95
-0.05 (-1.25%)
(As of 06/9/2023 ET)
Compare
Today's Range
$3.80
▼
$4.06
50-Day Range
$3.51
▼
$4.40
52-Week Range
$3.10
▼
$9.85
Volume
64,069 shs
Average Volume
73,165 shs
Market Capitalization
$131.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$19.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(Mar. 29)
-$0.31 Beat By $0.04
Consensus EPS
(Mar. 29)
-$0.35
Last Year's Q1 EPS
(3/24/2022)
-$0.40
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MIST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MIST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Milestone Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.45)($0.38)($0.41)
Q2 20233($0.49)($0.37)($0.42)
Q3 20233($0.50)($0.37)($0.43)
Q4 20232($0.46)($0.29)($0.38)
FY 202311($1.90)($1.41)($1.64)

MIST Earnings Date and Information

Milestone Pharmaceuticals last issued its earnings results on March 29th, 2023. The reported ($0.31) earnings per share for the quarter, topping analysts' consensus estimates of ($0.35) by $0.04. The business had revenue of $3.50 million for the quarter, compared to analyst estimates of $3.50 million. Milestone Pharmaceuticals has generated ($1.39) earnings per share over the last year (($1.39) diluted earnings per share). Earnings for Milestone Pharmaceuticals are expected to decrease in the coming year, from ($1.54) to ($1.75) per share. Milestone Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off prior year's report dates.

Milestone Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2023
(Estimated)		        
5/11/2023Q1 2023($0.38)($0.35)+$0.03($0.35)$1.00 million
3/29/2023Q4 2022($0.35)($0.31)+$0.04($0.31)$3.50 million$3.50 million
11/10/2022Q3 2022($0.41)($0.34)+$0.07($0.34)$1.50 million
8/10/2022Q2 2022($0.36)($0.39)($0.03)($0.39)
5/12/2022Q1 2022($0.39)($0.33)+$0.06($0.33)    
3/24/2022Q4 2021($0.40)($0.40)($0.40)
11/12/20219/30/2021($0.38)($0.34)+$0.04($0.34)
8/11/20216/30/2021($0.26)$0.02+$0.28$0.02$15.00 million
5/16/20213/31/2021($0.33)($0.30)+$0.03($0.30)
3/28/202112/31/2020($0.41)($0.13)+$0.28($0.23)
11/13/20209/30/2020($0.49)($0.40)+$0.09($0.40)  
8/12/20206/30/2020($0.51)($0.53)($0.02)($0.53)
5/14/20203/31/2020($0.74)($0.67)+$0.07($0.67)
3/6/202012/31/2019($0.52)($0.75)($0.23)($0.75)
11/13/2019Q3($0.4850)($0.52)($0.0350)($0.52)
8/13/2019Q2($0.4750)($1.04)($0.5650)($1.04)
5/24/2019Q1 2019($17.33)($17.33)($17.33)












Milestone Pharmaceuticals Earnings - Frequently Asked Questions

When is Milestone Pharmaceuticals's earnings date?

Milestone Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off last year's report dates. Learn more on MIST's earnings history.

Did Milestone Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Milestone Pharmaceuticals (NASDAQ:MIST) reported ($0.31) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.35) by $0.04. Learn more on analysts' earnings estimate vs. MIST's actual earnings.

How much revenue does Milestone Pharmaceuticals generate each year?

Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded annual revenue of $5 million.

How much profit does Milestone Pharmaceuticals generate each year?

Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded net income of -$58.39 million. MIST has generated -$1.39 earnings per share over the last four quarters.

What is Milestone Pharmaceuticals's EPS forecast for next year?

Milestone Pharmaceuticals's earnings are expected to decrease from ($1.54) per share to ($1.75) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:MIST) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -